[
  {
    "ts": "2025-11-10T09:17:25+00:00",
    "headline": "Norway wealth fund abstains from Novo board vote; Stock up on dropped Metsera bid",
    "summary": "Investing.com -- Norway’s sovereign wealth fund said on Monday it will abstain from voting on new board members, including the chair, at Novo Nordisk’s extraordinary shareholders’ meeting on November 14.",
    "url": "https://finance.yahoo.com/news/norway-wealth-fund-abstains-novo-091725443.html",
    "source": "Investing.com",
    "provider": "yfinance",
    "raw": {
      "id": "38f4b3ac-86d6-30c7-9b70-1e01d9424752",
      "content": {
        "id": "38f4b3ac-86d6-30c7-9b70-1e01d9424752",
        "contentType": "STORY",
        "title": "Norway wealth fund abstains from Novo board vote; Stock up on dropped Metsera bid",
        "description": "",
        "summary": "Investing.com -- Norway’s sovereign wealth fund said on Monday it will abstain from voting on new board members, including the chair, at Novo Nordisk’s extraordinary shareholders’ meeting on November 14.",
        "pubDate": "2025-11-10T09:17:25Z",
        "displayTime": "2025-11-10T09:17:25Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "Investing.com",
          "url": "https://www.investing.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/norway-wealth-fund-abstains-novo-091725443.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/norway-wealth-fund-abstains-novo-091725443.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NOVO-B.CO"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "MTSR"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-10T10:05:43+00:00",
    "headline": "Pfizer to Acquire Metsera Under Amended Deal; Novo Nordisk Says No Plan to Increase Offer for Metsera",
    "summary": "Metsera (MTSR) said late Friday it signed an amended merger agreement with Pfizer (PFE) under which",
    "url": "https://finance.yahoo.com/news/pfizer-acquire-metsera-under-amended-100543786.html",
    "source": "MT Newswires",
    "provider": "yfinance",
    "raw": {
      "id": "c2d6ce71-d9bd-3bf0-93f0-b2a19433e5e1",
      "content": {
        "id": "c2d6ce71-d9bd-3bf0-93f0-b2a19433e5e1",
        "contentType": "STORY",
        "title": "Pfizer to Acquire Metsera Under Amended Deal; Novo Nordisk Says No Plan to Increase Offer for Metsera",
        "description": "",
        "summary": "Metsera (MTSR) said late Friday it signed an amended merger agreement with Pfizer (PFE) under which",
        "pubDate": "2025-11-10T10:05:43Z",
        "displayTime": "2025-11-10T10:05:43Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "MT Newswires",
          "url": "https://www.mtnewswires.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/pfizer-acquire-metsera-under-amended-100543786.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/pfizer-acquire-metsera-under-amended-100543786.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MTSR"
            },
            {
              "symbol": "NOVO-B.CO"
            },
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": true,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-10T09:38:00+00:00",
    "headline": "Novo Nordisk Shares Rise After Withdrawal from Metsera Takeover Battle",
    "summary": "Shares climbed as much as 3.5% in early European trade after Pfizer agreed to buy Metsera in a deal that could be worth more than $10 billion following a heated takeover battle.",
    "url": "https://www.wsj.com/health/pharma/novo-nordisk-shares-rise-after-withdrawal-from-metsera-takeover-battle-89b46614?siteid=yhoof2&yptr=yahoo",
    "source": "The Wall Street Journal",
    "provider": "yfinance",
    "raw": {
      "id": "d5b47e8a-d903-348e-98e6-497e6f129b68",
      "content": {
        "id": "d5b47e8a-d903-348e-98e6-497e6f129b68",
        "contentType": "STORY",
        "title": "Novo Nordisk Shares Rise After Withdrawal from Metsera Takeover Battle",
        "description": "",
        "summary": "Shares climbed as much as 3.5% in early European trade after Pfizer agreed to buy Metsera in a deal that could be worth more than $10 billion following a heated takeover battle.",
        "pubDate": "2025-11-10T09:38:00Z",
        "displayTime": "2025-11-10T09:38:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/d5b47e8a-d903-348e-98e6-497e6f129b68/novo-nordisk-shares-rise.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/wsj.com/2372424f5139c905c960e20b3b91cc99",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/3RezSUeM_tSmgS.4CLrL0g--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/wsj.com/2372424f5139c905c960e20b3b91cc99.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/dkixDZf9CkcNbqHexcQcRw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/wsj.com/2372424f5139c905c960e20b3b91cc99.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "The Wall Street Journal",
          "url": "http://www.wsj.com/"
        },
        "canonicalUrl": {
          "url": "https://www.wsj.com/health/pharma/novo-nordisk-shares-rise-after-withdrawal-from-metsera-takeover-battle-89b46614?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            },
            {
              "symbol": "MTSR"
            },
            {
              "symbol": "NOVO-B.CO"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-10T09:18:45+00:00",
    "headline": "Novo Rises After Bowing Out of Metsera Takeover Battle",
    "summary": "Novo, the maker of Wegovy and Ozempic, decided to drop out of the running for Metsera on Saturday morning after Pfizer matched its latest offer in a bidding war that had pushed the price to levels that caused concern the bidders might be overpaying.  Adding to Novo’s obstacles, Metsera said it got a call from the US Federal Trade Commission flagging potential regulatory risks with the proposed Novo deal structure.  Pfizer agreed to pay $65.60 a share in cash for Metsera, as well as up to $20.65 a share contingent on certain milestones.",
    "url": "https://finance.yahoo.com/news/novo-rises-bowing-metsera-takeover-091845437.html",
    "source": "Bloomberg",
    "provider": "yfinance",
    "raw": {
      "id": "8ceadc74-594e-32d2-a64a-0aea1a5b22f7",
      "content": {
        "id": "8ceadc74-594e-32d2-a64a-0aea1a5b22f7",
        "contentType": "STORY",
        "title": "Novo Rises After Bowing Out of Metsera Takeover Battle",
        "description": "",
        "summary": "Novo, the maker of Wegovy and Ozempic, decided to drop out of the running for Metsera on Saturday morning after Pfizer matched its latest offer in a bidding war that had pushed the price to levels that caused concern the bidders might be overpaying.  Adding to Novo’s obstacles, Metsera said it got a call from the US Federal Trade Commission flagging potential regulatory risks with the proposed Novo deal structure.  Pfizer agreed to pay $65.60 a share in cash for Metsera, as well as up to $20.65 a share contingent on certain milestones.",
        "pubDate": "2025-11-10T09:18:45Z",
        "displayTime": "2025-11-10T09:18:45Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/bloomberg_holding_pen_162/08c13e6140038c2411667c1d223dd9e3",
          "originalWidth": 2000,
          "originalHeight": 1334,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/fmXrJtbI3H5zCMXkv.hLZw--~B/aD0xMzM0O3c9MjAwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/bloomberg_holding_pen_162/08c13e6140038c2411667c1d223dd9e3.cf.webp",
              "width": 2000,
              "height": 1334,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/2i3MlmOJYQDWFClE3QXhFg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/bloomberg_holding_pen_162/08c13e6140038c2411667c1d223dd9e3.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Bloomberg",
          "url": "https://www.bloomberg.com/company"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/novo-rises-bowing-metsera-takeover-091845437.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/novo-rises-bowing-metsera-takeover-091845437.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NOVO-B.CO"
            },
            {
              "symbol": "MTSR"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]